Skip to main content

Table 4 Average Daily Weight gain improvement/reduction between treatment groups over the finishing period and overall (* p = 0.0004 **p = 0.0014)

From: A field efficacy and safety trial in the Netherlands in pigs vaccinated at 3 weeks of age with a ready-to-use porcine circovirus type 2 and Mycoplasma hyopneumoniae combined vaccine

Compared groups ADWG over the finishing period (g/d) Reduction of ADWG over the finishing period Wean-to-finish ADWG (g/d) Reduction of ADWG from wean-to-finish
PCVM vs. NC PCVM: 842 −38 g/day* and 95% CI [−57, −19] PCVM: 660 −24 g/day** and 95% CI [−37, −11]
NC: 803 NC: 634
FLEX vs. NC FLEX: 827 −26 g/day* and 95% CI [−44, −7] FLEX: 650 −17 g/day** and 95% CI [−30, −3]
NC: 803 NC: 634
PCVM vs. FLEX PCVM: 842 −12 g/day and 95% CI [−31, 7] PCVM: 660 −8 g/day and 95% CI [−21, 6]
FLEX: 827 FLEX: 650